MASH Diagnostics: Advances, Limitations, and the Path Ahead (Session 2)

Nov 10 2025
Convention Center: Ballroom A, Level 3
11:00 AM - 12:30 PM

World Class Speakers

Rashmee Patil, MD
Abstract Presenter

Rashmee Patil, MD

Pinnacle Clinical Research
Jeffrey V. Lazarus, PhD
Abstract Presenter

Jeffrey V. Lazarus, PhD

Barcelona Institute for Global Health
Samer Gawrieh, MD
Moderator

Samer Gawrieh, MD

Indiana University School of Medicine
Monica A Tincopa, MD MSc
Moderator

Monica A Tincopa, MD MSc

University of California, San Diego

Description

Abstract Parallel sessions feature oral presentations from the authors of highly-rated abstracts submitted for presentation at The Liver Meeting.

Journey Maps

Presentations

11:30 AM - 11:45 AM
Apr 29 2026
Washington, D.C.

Performance of Expert Panel Criteria in Predicting At-Risk and Not-At-Risk MASH: Data from a Large Multi-Center Cohort

Rashmee Patil, MD , Abstract Presenter
MASLD
11:45 AM - 12:00 PM
Apr 29 2026
Washington, D.C.

Missed Liver Fibrosis Risk Stratification Opportunities in the All of Us Cohort in the United States

Jeffrey V. Lazarus, PhD , Abstract Presenter
MASLD

Objectives

  • Review recent advancements in noninvasive diagnostic tools and biomarkers for MASH, including their clinical utility and validation status
  • Discuss limitations, uncertainties, and practical challenges in implementing MASH diagnostics in clinical and research settings.